The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Catalyst Trusteeship Limited, acting as Debenture Trustee for debenture holders, has disclosed a release of 41,71,970 pledged equity shares (3.48% of total share capital) of Medplus Health Services on December 24, 2025. Prior to the release, Catalyst Trusteeship held 1,07,98,429 shares (9.01%) as encumbrance on behalf of debenture holders. After the release, its encumbered holding stands at 66,26,459 shares (5.53%). Catalyst Trusteeship is not a promoter or part of the promoter group — it acts solely in the capacity of a Debenture Trustee.
Reduction in encumbered (pledged) shares by ~3.48% is mildly positive, as it lowers the pledge overhang on the stock. However, since Catalyst Trusteeship is not a promoter, this is a routine debenture-related disclosure with limited direct impact on promoter control or share price.